Concepedia

Sean Bujarski

SB

Statistics

Publications

13

Citations

438

H-Index

12

Active since

2019

Affiliations

Oncotherapeutics (United States)(Current)

Institute for Myeloma & Bone Cancer Research

Cedars-Sinai Medical Center

Tarzana Treatment Centers

Emory University

Sean Bujarski is an author at Oncotherapeutics (United States) specializing in multiple myeloma, cancer immunology, and medicine.

ORCID

Publications per year

2019–2022

13

Publications

13

Response to mRNA vaccination for COVID-19 among patients with multiple myeloma

Samuel D. Stampfer, Marissa‐Skye Goldwater, Scott Jew et al. · Leukemia · 2021 · 93 citations · Full text

, , +12

Serum B-cell maturation antigen (BCMA) reduces binding of anti-BCMA antibody to multiple myeloma cells

Haiming Chen, Mingjie Li, Ning Xu et al. · Leukemia Research · 2019 · 70 citations

, , +9

JAK1/2 pathway inhibition suppresses M2 polarization and overcomes resistance of myeloma to lenalidomide by reducing TRIB1, MUC1, CD44, CXCL12, and CXCR4 expression

Haiming Chen, Mingjie Li, Eric Sanchez et al. · British Journal of Haematology · 2019 · 62 citations · Full text

, , +17

Serum BCMA levels predict outcomes in MGUS and smoldering myeloma patients

Alissa Visram, Camilia Soof, S. Vincent Rajkumar et al. · Blood Cancer Journal · 2021 · 50 citations · Full text

, , +7

Ruxolitinib reverses checkpoint inhibition by reducing programmed cell death ligand‐1 (PD‐L1) expression and increases anti‐tumour effects of T cells in multiple myeloma

Haiming Chen, Mingjie Li, Nicole Ng et al. · British Journal of Haematology · 2020 · 29 citations · Full text

, , +17

1–5 of 13